152 related articles for article (PubMed ID: 12101747)
1. [Future prospects for specific immunotherapy].
Sugaya M; Takenoyama M; Yasumoto K
Nihon Rinsho; 2002 May; 60 Suppl 5():609-13. PubMed ID: 12101747
[No Abstract] [Full Text] [Related]
2. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
3. Tumor specific CD8+ T cells in patients with lung cancer and healthy individuals.
Karanikas V; Germenis A
J BUON; 2009 Sep; 14 Suppl 1():S153-7. PubMed ID: 19785058
[TBL] [Abstract][Full Text] [Related]
4. Identification of hematological malignancy-associated antigens and clinical applications.
Fujiwara H
Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
[No Abstract] [Full Text] [Related]
5. Immunotherapy for pediatric central nervous system tumors.
Gardner SL; Ahmed N; Okada H
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S75-81. PubMed ID: 19896544
[No Abstract] [Full Text] [Related]
6. Cytotoxic T lymphocytes: the future of cancer stem cell eradication?
Saijo H; Hirohashi Y; Torigoe T; Kochin V; Takahashi H; Sato N
Immunotherapy; 2013 Jun; 5(6):549-51. PubMed ID: 23725275
[No Abstract] [Full Text] [Related]
7. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
8. [Adoptive immunotherapy for pancreatic cancer, using MUC1 specific CTL].
Masaki Y; Oka M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1679-80. PubMed ID: 8886044
[TBL] [Abstract][Full Text] [Related]
9. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
10. Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model.
Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
Immunol Lett; 2007 Nov; 113(2):90-8. PubMed ID: 17913245
[TBL] [Abstract][Full Text] [Related]
11. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
12. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
13. Immunotherapy of metastasis.
Dallal RM; Lotze MT
Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biology of lung cancer series].
Hiret S; Senellart H; Bennouna J
Rev Mal Respir; 2010 Oct; 27(8):954-8. PubMed ID: 20965409
[TBL] [Abstract][Full Text] [Related]
15. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
Rukavitsyn OA
Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
[No Abstract] [Full Text] [Related]
16. [Cellular immunotherapy for hematological malignancies].
Yasukawa M
Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
[No Abstract] [Full Text] [Related]
17. Targeted cellular immunotherapy with bifunctional antibodies.
Nelson H
Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
19. [Cellular immunotherapy against metastatic lung cancer].
Aruga A; Tanigawa K; Shimizu K; Sudo T; Takasaki K
Nihon Rinsho; 2002 May; 60 Suppl 5():621-4. PubMed ID: 12101749
[No Abstract] [Full Text] [Related]
20. [WT1 peptide-based immunotherapy].
Sugiyama H
Nihon Rinsho; 2005 Jun; 63(6):1101-9. PubMed ID: 15948398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
